Cell Medica begins production in Germany; Novasep inks $5.3M deal with Celladon; SGS rolls out new amino acid test;

> Cell Medica, a cellular immunotherapy company based in the U.K. has begun commercial cell therapy manufacturing at its facility at the Max-Delbrück-Centre of Molecular Medicine in Berlin-Buch, Germany. Story

> Novasep has given the green light to a $5.3 million deal with Celladon, a clinical-stage biotechnology company, to supply the drug substance for Mydicar. Article

> Swiss-based SGS has rolled out a new and more sensitive amino acid impurities test at its facilities in Germany. Report